Effect Of Combination Therapy Of Amantadine And Interferon In The Treatment Of Chronic HCV With Early Cirrhosis
Salwa Mohamed Fahmy Kamal;
Abstract
The present study was conducted on 170 patients with chronic hepatitis C with early cirrhosis who were classified into the following groups:
Group lA: 60 nai've patients with chronic hepatitis C with early cirrhosis who received combination therapy of
• interferon alpha 3 MIU three times weekly plus amantadine HCL 200 mg daily for 6 months.
Group lB: 50 patients in group IA (as 10 patients discontinued therapy after 6 months) who VjjJ,e continued the combination therapy of Interferon 3 MIU three
times weekly plus Amantadine HCL 200 mg daily for another 6 months completing one year therapy and followed up 6 months after stoppage therapy (sustained virological response).
Group I lA: 60 naive patients with chronic hepatitis C with early cirrhosis who were receivedinterferon alpha 3
MlU three times weekly as a monotherapy for 6
months.
Group liB: 50 patients 111 group IIA (as 10 patients discontinued therapy after 6 months) who were received interferon 3 MIU three times weekly as a
Group lA: 60 nai've patients with chronic hepatitis C with early cirrhosis who received combination therapy of
• interferon alpha 3 MIU three times weekly plus amantadine HCL 200 mg daily for 6 months.
Group lB: 50 patients in group IA (as 10 patients discontinued therapy after 6 months) who VjjJ,e continued the combination therapy of Interferon 3 MIU three
times weekly plus Amantadine HCL 200 mg daily for another 6 months completing one year therapy and followed up 6 months after stoppage therapy (sustained virological response).
Group I lA: 60 naive patients with chronic hepatitis C with early cirrhosis who were receivedinterferon alpha 3
MlU three times weekly as a monotherapy for 6
months.
Group liB: 50 patients 111 group IIA (as 10 patients discontinued therapy after 6 months) who were received interferon 3 MIU three times weekly as a
Other data
| Title | Effect Of Combination Therapy Of Amantadine And Interferon In The Treatment Of Chronic HCV With Early Cirrhosis | Other Titles | تاثير الجمع بين الانترفيرون والامانتدين فى علاج مرضى الاتهاب الكبدى الفيروسى المزمن (ج) فى وجود تليف كبدى | Authors | Salwa Mohamed Fahmy Kamal | Issue Date | 2002 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| سلوى محمد.pdf | 343.93 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.